Global Stroke Management Market: Industry Analysis and Forecast (2019-2026): By Type, Application, and Region.

Global Stroke Management Market: Industry Analysis and Forecast (2019-2026): By Type, Application, and Region.

Market Scenario

The Stroke Management market size is expected to grow from US$ XXBn in 2018 to USD XX Bn by 2026, at a CAGR of 5% during the forecast period. Stroke occurs due to interruptions in the blood supply to brain, either due to the rupture or blockage of blood vessels, leading to the death of brain cells. Global Stroke Management Market High blood pressure, high cholesterol levels and obesity, heart diseases, diabetes, sickle cell disease, smoking, alcoholic and excessive drug consumption are some of the major factors that can increase the chances of strokes. Blood pressure is one of the major causes where number of strokes that results in several death across the world. Also, heart diseases such as coronary artery disease, arrhythmia, atrial fibrillation, and enlarged heart chambers increase the risk of strokes. Factors such as technological advancement, growing aging population, and people suffering from diabetes are favoring the stroke market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavorable reimbursement scenario and high cost of treatments are hampering the market growth. Unhealthy lifestyle is another significant factor driving demand for stroke diagnostic products. Imaging studies are used in ischemic diagnosis for the detection of hemorrhage in the acute stroke patient, in order to assess the degree of brain injury, and to identify the vascular lesion responsible for the ischemic deficit. Some advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infracted and that which is potentially salvageable, thereby allowing better selection of patients likely to benefit from therapy. In 2018, the leading diagnostic segment was computed tomography. The highest share of CT techniques is attributable to widespread access and speed of acquisition. In the hyper acute phase, a noncontrast CT (NCCT) scan is usually ordered to exclude or confirm hemorrhage; it is highly sensitive for this indication. Ischemic stroke segment is expected to witness around XX% CAGR during the forecast timeframe owing to rising incidence of ischemic stroke in developed as well as developing countries. The market dominance of the North America is attributed to high percentage of patients suffering from strokes, in admiration with the technical advancement in the treatment procedure acute ischemic stroke in the region. It is then followed by Europe; the large population of baby boomers in Europe is one of the factors for a high market share in acute ischemic stroke diagnosis and treatment market. Country wise, the U.S., Canada are two of the major markets in North America. Germany, Italy, the U.K, and France are some of the dominant market in Europe, Japan, China and India are the major market of Asia Pacific region. The objective of the report is to present comprehensive analysis of Global Stroke Management Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Stroke Management Market dynamics, structure by analyzing the market segments, and project the Global Stroke Management Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Stroke Management Market make the report investor’s guide.

Global Stroke Management Market by type

• Diagnostics o Computed Tomography Scan (CT Scan), o Echocardiography Magnetic Resonance Imaging (MRI) o Carotid Ultrasound, o Cerebral Angiography, o Electrocardiography • Therapeutics o Tissue Plasminogen Activator, o Anticoagulant, o Antiplatelet, o Antihypertensive. .

Global Stroke Management Market by Application

• Ischemic Stroke • Haemorrhagic Stroke

Global Stroke Management Market BY Region

• Asia-Pacific • Europe • North America • Middle East & Africa • South America

Key players operating global stroke management market

• Abbott Laboratories • Covidien PLC • GE Healthcare • Hitachi, Ltd • Johnson and Johnson • Penumbra, Inc. • Philips Healthcare • Siemens Healthcare • Stryker Corporation (Concentric Medical, Inc.) • B. Braun Melsungen Ag • Boston Scientific Corporation • Cardinal Health, Inc. • Glaxosmithkline Plc • Medtronic Plc. • Merck & Co., Inc. • Bristol-Myers Squibb Company Global Atomic Force Microscopes Market 

Table of Contents

Stroke Management market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Stroke management Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Stroke management Market Analysis and Forecast 6.1. Global Stroke management Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Stroke management Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Stroke management Market Value Share Analysis, By Type 7.4. Global Stroke management Market Size (US$ Bn) Forecast, By Type 7.5. Global Stroke management Market Analysis, By Type 7.6. Global Stroke management Market Attractiveness Analysis, By Type 8. Global Stroke management Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Stroke management Market Value Share Analysis, By Application 8.4. Global Stroke management Market Size (US$ Bn) Forecast, By Application 8.5. Global Stroke management Market Analysis, By Application 8.6. Global Stroke management Market Attractiveness Analysis, By Application 9. Global Stroke management Market Analysis, by Region 9.1. Global Stroke management Market Value Share Analysis, by Region 9.2. Global Stroke management Market Size (US$ Bn) Forecast, by Region 9.3. Global Stroke management Market Attractiveness Analysis, by Region 10. North America Stroke management Market Analysis 10.1. Key Findings 10.2. North America Stroke management Market Overview 10.3. North America Stroke management Market Value Share Analysis, By Type 10.4. North America Stroke management Market Forecast, By Type 10.4.1. Diagnostics 10.4.1.1. Computed Tomography Scan (CT Scan), 10.4.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 10.4.1.3. Carotid Ultrasound, 10.4.1.4. Cerebral Angiography, 10.4.1.5. Electrocardiography 10.4.2. Therapeutics 10.4.2.1. Tissue Plasminogen Activator, 10.4.2.2. Anticoagulant, 10.4.2.3. Antiplatelet, 10.4.2.4. Antihypertensive 10.5. North America Stroke management Market Value Share Analysis, By Application 10.6. North America Stroke management Market Forecast, By Application 10.6.1. Ischemic Stroke 10.6.2. Haemorrhagic Stroke 10.7. North America Stroke management Market Value Share Analysis, by Country 10.8. North America Stroke management Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Stroke management Market Analysis, by Country 10.10. U.S. Stroke management Market Forecast, By Type 10.10.1. Diagnostics 10.10.1.1. Computed Tomography Scan (CT Scan), 10.10.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 10.10.1.3. Carotid Ultrasound, 10.10.1.4. Cerebral Angiography, 10.10.1.5. Electrocardiography 10.10.2. Therapeutics 10.10.2.1. Tissue Plasminogen Activator, 10.10.2.2. Anticoagulant, 10.10.2.3. Antiplatelet, 10.10.2.4. Antihypertensive 10.11. U.S. Stroke management Market Forecast, By Application 10.11.1. Ischemic Stroke 10.11.2. Haemorrhagic Stroke 10.12. Canada Stroke management Market Forecast, By Type 10.12.1. Diagnostics 10.12.1.1. Computed Tomography Scan (CT Scan), 10.12.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 10.12.1.3. Carotid Ultrasound, 10.12.1.4. Cerebral Angiography, 10.12.1.5. Electrocardiography 10.12.2. Therapeutics 10.12.2.1. Tissue Plasminogen Activator, 10.12.2.2. Anticoagulant, 10.12.2.3. Antiplatelet, 10.12.2.4. Antihypertensive 10.13. Canada Stroke management Market Forecast, By Application 10.13.1. Ischemic Stroke 10.13.2. Haemorrhagic Stroke 10.14. North America Stroke management Market Attractiveness Analysis 10.14.1. By Type 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Stroke management Market Analysis 11.1. Key Findings 11.2. Europe Stroke management Market Overview 11.3. Europe Stroke management Market Value Share Analysis, By Type 11.4. Europe Stroke management Market Forecast, By Type 11.4.1. Diagnostics 11.4.1.1. Computed Tomography Scan (CT Scan), 11.4.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.4.1.3. Carotid Ultrasound, 11.4.1.4. Cerebral Angiography, 11.4.1.5. Electrocardiography 11.4.2. Therapeutics 11.4.2.1. Tissue Plasminogen Activator, 11.4.2.2. Anticoagulant, 11.4.2.3. Antiplatelet, 11.4.2.4. Antihypertensive 11.5. Europe Stroke management Market Value Share Analysis, By Application 11.6. Europe Stroke management Market Forecast, By Application 11.6.1. Ischemic Stroke 11.6.2. Haemorrhagic Stroke 11.7. Europe Stroke management Market Value Share Analysis, by Country 11.8. Europe Stroke management Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Stroke management Market Analysis, by Country 11.10. Germany Stroke management Market Forecast, By Type 11.10.1. Diagnostics 11.10.1.1. Computed Tomography Scan (CT Scan), 11.10.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.10.1.3. Carotid Ultrasound, 11.10.1.4. Cerebral Angiography, 11.10.1.5. Electrocardiography 11.10.2. Therapeutics 11.10.2.1. Tissue Plasminogen Activator, 11.10.2.2. Anticoagulant, 11.10.2.3. Antiplatelet, 11.10.2.4. Antihypertensive 11.11. Germany Stroke management Market Forecast, By Application 11.11.1. Ischemic Stroke 11.11.2. Haemorrhagic Stroke 11.12. U.K. Stroke management Market Forecast, By Type 11.12.1. Diagnostics 11.12.1.1. Computed Tomography Scan (CT Scan), 11.12.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.12.1.3. Carotid Ultrasound, 11.12.1.4. Cerebral Angiography, 11.12.1.5. Electrocardiography 11.12.2. Therapeutics 11.12.2.1. Tissue Plasminogen Activator, 11.12.2.2. Anticoagulant, 11.12.2.3. Antiplatelet, 11.12.2.4. Antihypertensive 11.13. U.K. Stroke management Market Forecast, By Application 11.13.1. Ischemic Stroke 11.13.2. Haemorrhagic Stroke 11.14. France Stroke management Market Forecast, By Type 11.14.1. Diagnostics 11.14.1.1. Computed Tomography Scan (CT Scan), 11.14.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.14.1.3. Carotid Ultrasound, 11.14.1.4. Cerebral Angiography, 11.14.1.5. Electrocardiography 11.14.2. Therapeutics 11.14.2.1. Tissue Plasminogen Activator, 11.14.2.2. Anticoagulant, 11.14.2.3. Antiplatelet, 11.14.2.4. Antihypertensive 11.15. France Stroke management Market Forecast, By Application 11.15.1. Ischemic Stroke 11.15.2. Haemorrhagic Stroke 11.16. Italy Stroke management Market Forecast, By Type 11.16.1. Diagnostics 11.16.1.1. Computed Tomography Scan (CT Scan), 11.16.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.16.1.3. Carotid Ultrasound, 11.16.1.4. Cerebral Angiography, 11.16.1.5. Electrocardiography 11.16.2. Therapeutics 11.16.2.1. Tissue Plasminogen Activator, 11.16.2.2. Anticoagulant, 11.16.2.3. Antiplatelet, 11.16.2.4. Antihypertensive 11.17. Italy Stroke management Market Forecast, By Application 11.17.1. Ischemic Stroke 11.17.2. Haemorrhagic Stroke 11.18. Spain Stroke management Market Forecast, By Type 11.18.1. Diagnostics 11.18.1.1. Computed Tomography Scan (CT Scan), 11.18.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.18.1.3. Carotid Ultrasound, 11.18.1.4. Cerebral Angiography, 11.18.1.5. Electrocardiography 11.18.2. Therapeutics 11.18.2.1. Tissue Plasminogen Activator, 11.18.2.2. Anticoagulant, 11.18.2.3. Antiplatelet, 11.18.2.4. Antihypertensive 11.19. Spain Stroke management Market Forecast, By Application 11.19.1. Ischemic Stroke 11.19.2. Haemorrhagic Stroke 11.20. Rest of Europe Stroke management Market Forecast, By Type 11.20.1. Diagnostics 11.20.1.1. Computed Tomography Scan (CT Scan), 11.20.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 11.20.1.3. Carotid Ultrasound, 11.20.1.4. Cerebral Angiography, 11.20.1.5. Electrocardiography 11.20.2. Therapeutics 11.20.2.1. Tissue Plasminogen Activator, 11.20.2.2. Anticoagulant, 11.20.2.3. Antiplatelet, 11.20.2.4. Antihypertensive 11.21. Rest of Europe Stroke management Market Forecast, By Application 11.21.1. Ischemic Stroke 11.21.2. Haemorrhagic Stroke 11.22. Europe Stroke management Market Attractiveness Analysis 11.22.1. By Type 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Stroke management Market Analysis 12.1. Key Findings 12.2. Asia Pacific Stroke management Market Overview 12.3. Asia Pacific Stroke management Market Value Share Analysis, By Type 12.4. Asia Pacific Stroke management Market Forecast, By Type 12.4.1. Diagnostics 12.4.1.1. Computed Tomography Scan (CT Scan), 12.4.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 12.4.1.3. Carotid Ultrasound, 12.4.1.4. Cerebral Angiography, 12.4.1.5. Electrocardiography 12.4.2. Therapeutics 12.4.2.1. Tissue Plasminogen Activator, 12.4.2.2. Anticoagulant, 12.4.2.3. Antiplatelet, 12.4.2.4. Antihypertensive 12.5. Asia Pacific Stroke management Market Value Share Analysis, By Application 12.6. Asia Pacific Stroke management Market Forecast, By Application 12.6.1. Ischemic Stroke 12.6.2. Haemorrhagic Stroke, 12.7. Asia Pacific Stroke management Market Value Share Analysis, by Country 12.8. Asia Pacific Stroke management Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Stroke management Market Analysis, by Country 12.10. China Stroke management Market Forecast, By Type 12.10.1. Diagnostics 12.10.1.1. Computed Tomography Scan (CT Scan), 12.10.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 12.10.1.3. Carotid Ultrasound, 12.10.1.4. Cerebral Angiography, 12.10.1.5. Electrocardiography 12.10.2. Therapeutics 12.10.2.1. Tissue Plasminogen Activator, 12.10.2.2. Anticoagulant, 12.10.2.3. Antiplatelet, 12.10.2.4. Antihypertensive 12.11. China Stroke management Market Forecast, By Application 12.11.1. Ischemic Stroke 12.11.2. Haemorrhagic Stroke 12.12. India Stroke management Market Forecast, By Type 12.12.1. Diagnostics 12.12.1.1. Computed Tomography Scan (CT Scan), 12.12.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 12.12.1.3. Carotid Ultrasound, 12.12.1.4. Cerebral Angiography, 12.12.1.5. Electrocardiography 12.12.2. Therapeutics 12.12.2.1. Tissue Plasminogen Activator, 12.12.2.2. Anticoagulant, 12.12.2.3. Antiplatelet, 12.12.2.4. Antihypertensive 12.13. India Stroke management Market Forecast, By Application 12.13.1. Ischemic Stroke 12.13.2. Haemorrhagic Stroke 12.14. Japan Stroke management Market Forecast, By Type 12.14.1. Diagnostics 12.14.1.1. Computed Tomography Scan (CT Scan), 12.14.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 12.14.1.3. Carotid Ultrasound, 12.14.1.4. Cerebral Angiography, 12.14.1.5. Electrocardiography 12.14.2. Therapeutics 12.14.2.1. Tissue Plasminogen Activator, 12.14.2.2. Anticoagulant, 12.14.2.3. Antiplatelet, 12.14.2.4. Antihypertensive 12.15. Japan Stroke management Market Forecast, By Application 12.15.1. Ischemic Stroke 12.15.2. Haemorrhagic Stroke 12.16. ASEAN Stroke management Market Forecast, By Type 12.16.1. Diagnostics 12.16.1.1. Computed Tomography Scan (CT Scan), 12.16.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 12.16.1.3. Carotid Ultrasound, 12.16.1.4. Cerebral Angiography, 12.16.1.5. Electrocardiography 12.16.2. Therapeutics 12.16.2.1. Tissue Plasminogen Activator, 12.16.2.2. Anticoagulant, 12.16.2.3. Antiplatelet, 12.16.2.4. Antihypertensive 12.17. ASEAN Stroke management Market Forecast, By Application 12.17.1. Ischemic Stroke 12.17.2. Haemorrhagic Stroke 12.18. Rest of Asia Pacific Stroke management Market Forecast, By Type 12.18.1. Diagnostics 12.18.1.1. Computed Tomography Scan (CT Scan), 12.18.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 12.18.1.3. Carotid Ultrasound, 12.18.1.4. Cerebral Angiography, 12.18.1.5. Electrocardiography 12.18.2. Therapeutics 12.18.2.1. Tissue Plasminogen Activator, 12.18.2.2. Anticoagulant, 12.18.2.3. Antiplatelet, 12.18.2.4. Antihypertensive 12.19. Rest of Asia Pacific Stroke management Market Forecast, By Application 12.19.1. Ischemic Stroke 12.19.2. Haemorrhagic Stroke 12.20. Asia Pacific Stroke management Market Attractiveness Analysis 12.20.1. By Type 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Stroke management Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Stroke management Market Overview 13.3. Middle East & Africa Stroke management Market Value Share Analysis, By Type 13.4. Middle East & Africa Stroke management Market Forecast, By Type 13.4.1. Diagnostics 13.4.1.1. Computed Tomography Scan (CT Scan), 13.4.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 13.4.1.3. Carotid Ultrasound, 13.4.1.4. Cerebral Angiography, 13.4.1.5. Electrocardiography 13.4.2. Therapeutics 13.4.2.1. Tissue Plasminogen Activator, 13.4.2.2. Anticoagulant, 13.4.2.3. Antiplatelet, 13.4.2.4. Antihypertensive 13.5. Middle East & Africa Stroke management Market Value Share Analysis, By Application 13.6. Middle East & Africa Stroke management Market Forecast, By Application 13.6.1. Ischemic Stroke 13.6.2. Haemorrhagic Stroke 13.7. Middle East & Africa Stroke management Market Value Share Analysis, by Country 13.8. Middle East & Africa Stroke management Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Stroke management Market Analysis, by Country 13.10. GCC Stroke management Market Forecast, By Type 13.10.1. Diagnostics 13.10.1.1. Computed Tomography Scan (CT Scan), 13.10.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 13.10.1.3. Carotid Ultrasound, 13.10.1.4. Cerebral Angiography, 13.10.1.5. Electrocardiography 13.10.2. Therapeutics 13.10.2.1. Tissue Plasminogen Activator, 13.10.2.2. Anticoagulant, 13.10.2.3. Antiplatelet, 13.10.2.4. Antihypertensive 13.11. GCC Stroke management Market Forecast, By Application 13.11.1. Ischemic Stroke 13.11.2. Haemorrhagic Stroke 13.12. South Africa Stroke management Market Forecast, By Type 13.12.1. Diagnostics 13.12.1.1. Computed Tomography Scan (CT Scan), 13.12.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 13.12.1.3. Carotid Ultrasound, 13.12.1.4. Cerebral Angiography, 13.12.1.5. Electrocardiography 13.12.2. Therapeutics 13.12.2.1. Tissue Plasminogen Activator, 13.12.2.2. Anticoagulant, 13.12.2.3. Antiplatelet, 13.12.2.4. Antihypertensive 13.13. South Africa Stroke management Market Forecast, By Application 13.13.1. Ischemic Stroke 13.13.2. Haemorrhagic Stroke 13.14. Rest of Middle East & Africa Stroke management Market Forecast, By Type 13.14.1. Diagnostics 13.14.1.1. Computed Tomography Scan (CT Scan), 13.14.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 13.14.1.3. Carotid Ultrasound, 13.14.1.4. Cerebral Angiography, 13.14.1.5. Electrocardiography 13.14.2. Therapeutics 13.14.2.1. Tissue Plasminogen Activator, 13.14.2.2. Anticoagulant, 13.14.2.3. Antiplatelet, 13.14.2.4. Antihypertensive 13.15. Rest of Middle East & Africa Stroke management Market Forecast, By Application 13.15.1. Ischemic Stroke 13.15.2. Haemorrhagic Stroke 13.16. Middle East & Africa Stroke management Market Attractiveness Analysis 13.16.1. By Type 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Stroke management Market Analysis 14.1. Key Findings 14.2. South America Stroke management Market Overview 14.3. South America Stroke management Market Value Share Analysis, By Type 14.4. South America Stroke management Market Forecast, By Type 14.4.1. Diagnostics 14.4.1.1. Computed Tomography Scan (CT Scan), 14.4.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 14.4.1.3. Carotid Ultrasound, 14.4.1.4. Cerebral Angiography, 14.4.1.5. Electrocardiography 14.4.2. Therapeutics 14.4.2.1. Tissue Plasminogen Activator, 14.4.2.2. Anticoagulant, 14.4.2.3. Antiplatelet, 14.4.2.4. Antihypertensive 14.5. South America Stroke management Market Value Share Analysis, By Application 14.6. South America Stroke management Market Forecast, By Application 14.6.1. Ischemic Stroke 14.6.2. Haemorrhagic Stroke 14.7. South America Stroke management Market Value Share Analysis, by Country 14.8. South America Stroke management Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Stroke management Market Forecast, By Type 14.9.1. Diagnostics 14.9.1.1. Computed Tomography Scan (CT Scan), 14.9.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 14.9.1.3. Carotid Ultrasound, 14.9.1.4. Cerebral Angiography, 14.9.1.5. Electrocardiography 14.9.2. Therapeutics 14.9.2.1. Tissue Plasminogen Activator, 14.9.2.2. Anticoagulant, 14.9.2.3. Antiplatelet, 14.9.2.4. Antihypertensive 14.10. Brazil Stroke management Market Forecast, By Application 14.10.1. Ischemic Stroke 14.10.2. Haemorrhagic Stroke 14.11. Mexico Stroke management Market Forecast, By Type 14.11.1. Diagnostics 14.11.1.1. Computed Tomography Scan (CT Scan), 14.11.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 14.11.1.3. Carotid Ultrasound, 14.11.1.4. Cerebral Angiography, 14.11.1.5. Electrocardiography 14.11.2. Therapeutics 14.11.2.1. Tissue Plasminogen Activator, 14.11.2.2. Anticoagulant, 14.11.2.3. Antiplatelet, 14.11.2.4. Antihypertensive 14.12. Mexico Stroke management Market Forecast, By Application 14.12.1. Ischemic Stroke 14.12.2. Haemorrhagic Stroke 14.13. Rest of South America Stroke management Market Forecast, By Type 14.13.1. Diagnostics 14.13.1.1. Computed Tomography Scan (CT Scan), 14.13.1.2. Echocardiography Magnetic Resonance Imaging (MRI) 14.13.1.3. Carotid Ultrasound, 14.13.1.4. Cerebral Angiography, 14.13.1.5. Electrocardiography 14.13.2. Therapeutics 14.13.2.1. Tissue Plasminogen Activator, 14.13.2.2. Anticoagulant, 14.13.2.3. Antiplatelet, 14.13.2.4. Antihypertensive 14.14. Rest of South America Stroke management Market Forecast, By Application 14.14.1. Ischemic Stroke 14.14.2. Haemorrhagic Stroke 14.15. South America Stroke management Market Attractiveness Analysis 14.15.1. By Type 14.15.2. By Application 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Type Launches and Type Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Abbott Laboratories 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Type Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Covidien PLC 15.3.3. GE Healthcare 15.3.4. Hitachi, Ltd 15.3.5. Johnson and Johnson 15.3.6. Penumbra, Inc. 15.3.7. Philips Healthcare 15.3.8. Siemens Healthcare 15.3.9. Stryker Corporation (Concentric Medical, Inc.) 15.3.10. B. Braun Melsungen Ag 15.3.11. Boston Scientific Corporation 15.3.12. Cardinal Health, Inc. 15.3.13. Glaxosmithkline Plc 15.3.14. Medtronic Plc. 15.3.15. Merck & Co., Inc. 15.3.16. Bristol-Myers Squibb Company 16. Primary Key Insights

About This Report

Report ID35987
Published DateNov 2019
Contact Us
Call Now